Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Get Free Report)'s stock price traded down 0.6% on Thursday . The company traded as low as $11.18 and last traded at $11.10. 1,127 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 36,270 shares. The stock had previously closed at $11.17.
Aimei Health Technology Price Performance
The firm's 50 day simple moving average is $11.08 and its 200-day simple moving average is $10.91.
Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last issued its earnings results on Friday, March 28th. The company reported $0.05 earnings per share for the quarter.
Hedge Funds Weigh In On Aimei Health Technology
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Polar Asset Management Partners Inc. acquired a new position in shares of Aimei Health Technology during the 1st quarter worth $110,000. Harraden Circle Investments LLC acquired a new stake in shares of Aimei Health Technology during the 4th quarter valued at approximately $1,117,000. Quarry LP purchased a new stake in shares of Aimei Health Technology during the 4th quarter worth approximately $1,605,000. Centiva Capital LP grew its holdings in shares of Aimei Health Technology by 1.4% in the 4th quarter. Centiva Capital LP now owns 232,693 shares of the company's stock worth $2,460,000 after acquiring an additional 3,100 shares during the period. Finally, Berkley W R Corp acquired a new stake in shares of Aimei Health Technology in the 4th quarter worth approximately $4,750,000. Institutional investors and hedge funds own 45.58% of the company's stock.
Aimei Health Technology Company Profile
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
